An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 020646
Company: CEPHALON

Medication Guide

Other Important Information from FDA

Products on NDA 020646

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
GABITRIL	TIAGABINE HYDROCHLORIDE	4MG	TABLET;ORAL	Prescription	AB	Yes	Yes
GABITRIL	TIAGABINE HYDROCHLORIDE	12MG	TABLET;ORAL	Prescription	AB	Yes	No
GABITRIL	TIAGABINE HYDROCHLORIDE	16MG	TABLET;ORAL	Prescription	AB	Yes	No
GABITRIL	TIAGABINE HYDROCHLORIDE	20MG	TABLET;ORAL	Discontinued	None	No	No
GABITRIL	TIAGABINE HYDROCHLORIDE	2MG	TABLET;ORAL	Prescription	AB	Yes	No
GABITRIL	TIAGABINE HYDROCHLORIDE	6MG	TABLET;ORAL	Discontinued	None	No	No
GABITRIL	TIAGABINE HYDROCHLORIDE	8MG	TABLET;ORAL	Discontinued	None	No	No
GABITRIL	TIAGABINE HYDROCHLORIDE	10MG	TABLET;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 020646

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/30/1997	ORIG-1	Approval	Type 1 - New Molecular Entity	STANDARD	Review	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020646_gabitril_toc.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/03/2023	SUPPL-23	Labeling-Medication Guide, Labeling-Container/Carton Labels, Labeling-Package Insert	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/020646Orig1s023ltr.pdf
08/09/2016	SUPPL-21	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020646s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020646Orig1s021ltr.pdf
01/25/2012	SUPPL-20	REMS-Modified	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020646s020ltr.pdf
11/04/2015	SUPPL-18	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020646s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020646Orig1s018ltr.pdf
10/11/2010	SUPPL-17	Labeling, REMS-Proposal	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020646s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020646s017ltr.pdf
04/23/2009	SUPPL-16	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020646s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020646s016ltr.pdf
11/29/2005	SUPPL-15	Manufacturing (CMC)	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020646s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020646s015ltr.pdf
02/14/2005	SUPPL-14	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020646s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020646s014ltr.pdf
10/03/2001	SUPPL-11	Manufacturing (CMC)		Label is not available on this site.
10/03/2001	SUPPL-10	Manufacturing (CMC)-Packaging		Label is not available on this site.
07/27/2001	SUPPL-9	Manufacturing (CMC)		Label is not available on this site.
05/16/2000	SUPPL-8	Manufacturing (CMC)		Label is not available on this site.
05/17/2000	SUPPL-7	Manufacturing (CMC)-Control		Label is not available on this site.
08/23/1999	SUPPL-6	Manufacturing (CMC)-Expiration Date		Label is not available on this site.
04/16/1999	SUPPL-5	Labeling		Label is not available on this site.
04/16/1999	SUPPL-4	Manufacturing (CMC)		Label is not available on this site.
07/31/1998	SUPPL-3	Manufacturing (CMC)-Control		Label is not available on this site.
05/08/1998	SUPPL-2	Manufacturing (CMC)-Packaging		Label is not available on this site.
10/09/1997	SUPPL-1	Manufacturing (CMC)-Control		Label is not available on this site.

Labels for NDA 020646

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
08/09/2016	SUPPL-21	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020646s021lbl.pdf
11/04/2015	SUPPL-18	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020646s018lbl.pdf
10/11/2010	SUPPL-17	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020646s017lbl.pdf
10/11/2010	SUPPL-17	REMS-Proposal	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020646s017lbl.pdf
04/23/2009	SUPPL-16	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020646s016lbl.pdf
11/29/2005	SUPPL-15	Manufacturing (CMC)	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020646s015lbl.pdf
02/14/2005	SUPPL-14	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020646s014lbl.pdf

Therapeutic Equivalents for NDA 020646

GABITRIL

TABLET;ORAL; 4MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
GABITRIL	TIAGABINE HYDROCHLORIDE	4MG	TABLET;ORAL	Prescription	Yes	AB	020646	CEPHALON
TIAGABINE HYDROCHLORIDE	TIAGABINE HYDROCHLORIDE	4MG	TABLET;ORAL	Prescription	No	AB	214816	MSN
TIAGABINE HYDROCHLORIDE	TIAGABINE HYDROCHLORIDE	4MG	TABLET;ORAL	Prescription	No	AB	077555	SUN PHARM INDS

TABLET;ORAL; 12MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
GABITRIL	TIAGABINE HYDROCHLORIDE	12MG	TABLET;ORAL	Prescription	Yes	AB	020646	CEPHALON
TIAGABINE HYDROCHLORIDE	TIAGABINE HYDROCHLORIDE	12MG	TABLET;ORAL	Prescription	No	AB	214816	MSN

TABLET;ORAL; 16MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
GABITRIL	TIAGABINE HYDROCHLORIDE	16MG	TABLET;ORAL	Prescription	Yes	AB	020646	CEPHALON
TIAGABINE HYDROCHLORIDE	TIAGABINE HYDROCHLORIDE	16MG	TABLET;ORAL	Prescription	No	AB	214816	MSN

TABLET;ORAL; 2MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
GABITRIL	TIAGABINE HYDROCHLORIDE	2MG	TABLET;ORAL	Prescription	Yes	AB	020646	CEPHALON
TIAGABINE HYDROCHLORIDE	TIAGABINE HYDROCHLORIDE	2MG	TABLET;ORAL	Prescription	No	AB	214816	MSN
TIAGABINE HYDROCHLORIDE	TIAGABINE HYDROCHLORIDE	2MG	TABLET;ORAL	Prescription	No	AB	077555	SUN PHARM INDS

Top